title: Safety of magnetic resonance contrast media: a review with special focus on nephrogenic systemic fibrosis.
authors: From the *Department of Radiology, University Hospital of Cologne, Cologne, Germany; University Medical Center Mannheim, Heidelberg University, Mannheim, Germany; and †University of Toronto, Toronto, Canada.
authors: Stefan
authors: S
authors: Haneder
authors: Walter
authors: W
authors: Kucharczyk
authors: Stefan Oswald
authors: SO
authors: Schoenberg
authors: Henrik Jakob
authors: HJ
authors: Michaely
mesh_terms: D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D019317:Evidence-Based Medicine; D005682:Gadolinium / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000009:adverse effects*; D054989:Nephrogenic Fibrosing Dermopathy / Q000139:chemically induced* / Q000517:prevention & control*; D061214:Patient Safety; D018570:Risk Assessment; D017751:Safety Management
chemical_list: D003287:Contrast Media; D005682:Gadolinium